Company Analysis Hisamitsu Pharmaceutical Co., Inc.
1. Summary
Advantages
- Price (32.3 $) is less than fair price (38.1 $)
- The stock's return over the last year (31.52%) is higher than the sector average (-30.77%).
Disadvantages
- Dividends (0%) are below the sector average (1.68%).
- Current debt level 0.6387% has increased over 5 years from 0.6117%.
- The company's current efficiency (ROE=5.36%) is lower than the sector average (ROE=14.36%)
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Hisamitsu Pharmaceutical Co., Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | 0% | -33.1% | 0.6% |
| 90 days | 0% | -28.9% | 8.5% |
| 1 year | 31.5% | -30.8% | 16.7% |
HTSUF vs Sector: Hisamitsu Pharmaceutical Co., Inc. has outperformed the "Healthcare" sector by 62.29% over the past year.
HTSUF vs Market: Hisamitsu Pharmaceutical Co., Inc. has outperformed the market by 14.78% over the past year.
Stable price: HTSUF is not significantly more volatile than the rest of the market on "OTC" over the last 3 months, with typical variations of +/- 5% per week.
Long period: HTSUF with weekly volatility of 0.6062% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Below fair price: The current price (32.3 $) is lower than the fair price (38.1 $).
Price not significantly lower than the fair price: The current price (32.3 $) is slightly lower than the fair price by 18%.
4.2. P/E
P/E vs Sector: The company's P/E (28.21) is lower than that of the sector as a whole (46.55).
P/E vs Market: The company's P/E (28.21) is lower than that of the market as a whole (50.4).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (1.48) is lower than that of the sector as a whole (5.33).
P/BV vs Market: The company's P/BV (1.48) is lower than that of the market as a whole (6.85).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.78) is lower than that of the sector as a whole (4.32).
P/S vs Market: The company's P/S indicator (2.78) is lower than that of the market as a whole (15.61).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (15.47) is lower than that of the sector as a whole (17.45).
EV/Ebitda vs Market: The company's EV/Ebitda (15.47) is lower than that of the market as a whole (27.37).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -5.05% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-5.05%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.67%).
5.4. ROE
ROE vs Sector: The company's ROE (5.36%) is lower than that of the sector as a whole (14.36%).
ROE vs Market: The company's ROE (5.36%) is lower than that of the market as a whole (51.72%).
5.5. ROA
ROA vs Sector: The company's ROA (4.35%) is lower than that of the sector as a whole (7.33%).
ROA vs Market: The company's ROA (4.35%) is lower than that of the market as a whole (36.04%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.1%) is lower than that of the sector as a whole (14.04%).
ROIC vs Market: The company's ROIC (7.1%) is lower than that of the market as a whole (10.91%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.68%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 0% has been steadily paid over the past 7 years, DSI=0.71.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 0 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (47.09%) are at a comfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
